$HUM

US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected - Humana

Humana Inc. (NYSE:HUM) said it will exit additional Medicare Advantage plans in 2027, affecting about 600,000 members. The company links the move to improving profitability and reshaping its portfolio to reach a sustainable 3% pre-tax margin by 2028. It expects to retain just over 40% of affected members and recapture many through other plans. Shares fell 5.99% to $365.41.

Original reporting
Published Jul 30, 2026, 12:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected - Humana — source image
Decision brief

The 30-second read

$HUMBullishMed
01

Why it matters

Humana is reshaping its Medicare Advantage portfolio by exiting lower-return plans in 2027, targeting a sustainable 3% pre-tax margin by 2028 while expecting to retain just over 40% of affected members through other plans.

02

Market read

A concrete portfolio action (plan exits) with member impact and a stated margin target can change near-term earnings expectations and risk for MA insurers.

03

What to watch

The article does not quantify expected cost savings, timing of contract terminations, or how benefit adjustments will affect medical cost trends versus revenue, which could swing the margin outcome.

Relevance 7/10Novelty 6/10Timing: today’s premarket and post-close positioning after the 2027 plan-exit announcement

Background

Medicare Advantage is the privately managed Medicare program where insurers receive government payments to cover eligible seniors.

Company-level read

Ticker impact

$HUMBullishMedium confidence
Context

Humana plans to exit additional Medicare Advantage plans in 2027, affecting about 600,000 members, to improve profitability and margins.

Expected impact

Near-term sentiment likely supportive due to margin focus, but investors may weigh execution risk and member retention assumptions.

Evidence & confidence

The article provides specific strategic targets (exit lower-return plans, retain just over 40% of affected members) and a margin commitment (3% pre-tax by 2028), which can re-rate earnings expectations, though the magnitude depends on actual contract economics and retention outcomes.

Market effects

Medicare Advantage peers may face read-across on competitive pressure and pricing for lower-return plan segments.

No specific regional impact disclosed beyond US Medicare Advantage membership.

Limited, as the event is US healthcare reimbursement and plan portfolio management.

Counterpoint

Exiting plans could signal underlying margin pressure in certain geographies or risk adjustment dynamics, and member retention may be harder than assumed.

Key entities

  • Humana Inc.

    US Medicare Advantage insurer planning additional 2027 plan exits to improve profitability and margins.

  • Celeste Mellet

    Humana CFO who discussed the 2027 strategy and margin commitment on the second-quarter earnings call.

Related articles

$HUMMedAI 8/10

HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy

Humana reported Q2 revenue of $40.89B, slightly above analysts’ $40.63B estimate, and adjusted EPS of $7.61 versus $7.00. Management reiterated full-year adjusted EPS guidance of $9 (midpoint). The company cited margin initiatives, Stars program progress, and plan mix changes, and said it will use $900M from divesting its Gentiva stake to fund the MaxHealth acquisition.

$HUMMed

Humana Inc. Q2 2026 Earnings Call Summary

Strategic Execution and Performance Drivers Management attributes year-to-date performance to cost trends tracking in line with expectations, specifically citing favorability in inpatient care among members engaged with value-based providers. The company is executing a multi-year operating model transformation aimed at simplifying infrastructure and centralizing functions like utilization management to drive G&A savings and service consistency.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

$HUMMedAI 8/10

Humana Shares Fall Despite Second-Quarter Earnings Beat and Reaffirmed Outlook

Humana Inc. (NYSE:HUM) shares fell nearly 9% in pre-market trading on Wednesday despite the health insurer reporting second-quarter earnings and revenue that exceeded Wall Street expectations while reaffirming its full-year adjusted earnings guidance. The company posted adjusted earnings of $7.61 per share, surpassing analysts' consensus estimate of $7.23. Revenue for the quarter increased to $40.89 billion, ahead of the expected $40.56 billion.